LENSAR, Inc. (LNSR)
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
$8.58+4.00%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
QuarterlyIQ Insights · LNSR
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | -29.8% |
| Our one-year growth estimate | diamond |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-09-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| 16.6% |
Growth built into the price is above our model estimate.
The price assumes 46.4 percentage points less one-year growth.
The one-year revenue growth assumption on Valuation.
Worth watching into the next print: this name has erratic recent earnings surprises and is a smaller-cap name (higher miss base rate). A fundamental tilt, not a price call.
Model as of 2026-09-04 · Compared with 87 industry peers · Company calendar date is not available
LNSR — CFO transition
Dated 2026-05-29
Interim Chief Financial Officer — Michael A. Rossi: The company appointed an Interim Chief Financial Officer from an external source.
Why it matters: If revenue growth in the health care sector picks up, it could benefit LENSAR. It may indicate a broader recovery in the industry.
Supportive ifHealth care revenue growth is speeding up again. This shows strength in the sector.
Worry ifRevenue growth keeps slowing down. This shows weakness in the sector.
Why it matters: A smaller drop in total revenue shows market conditions are getting better after the merger.
Supportive ifQ2 total revenue decline is less than 5% compared to Q2 2025.
Worry ifQ2 total revenue decline is greater than 10% compared to Q2 2025.
Why it matters: More system placements show demand is coming back and operations are stable.
Supportive ifTotal system placements in Q2 reach or exceed 10 units.
Worry ifTotal system placements in Q2 are fewer than 5 units.
Why it matters: Cash levels impact how the company can pay for operations and grow.
Worry ifCash, cash equivalents, and investments are over $13.5 million.
Less concerning ifCash, cash equivalents, and investments drop below $13.5 million.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$189 on $10,000 · ±1.9% | How much price usually moves either way. |
| Bad day | $456 loss on $10,000 · 4.6% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $6,064 loss on $10,000 · 60.6% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Why it matters: Changes in consumer prices can impact healthcare spending. This can affect LENSAR's sales.
Watch forThe CPI report shows inflation under 2%. This means consumer spending is stable.
Also watch forThe CPI report shows inflation over 3%. This suggests less consumer spending.
Why it matters: This is key to LENSAR's growth strategy. A rise would show progress despite recent declines.
Supportive ifQ2 recurring revenue from system placements increases year over year from $13.4M.
Worry ifIn Q2, recurring revenue from system placements goes down compared to last year.
Why it matters: More system placements show the market likes the product. This can increase revenue.
Supportive ifIn Q2 2026, system placements are over 7 units. This shows recovery.
Worry ifSystem placements in Q2 2026 remain below 7 units.
Why it matters: The new CFO's plans may change how the company manages money and operations.
Watch forThe new CFO outlines a clear strategic plan that supports growth.
Also watch forThe new CFO provides vague or no strategic direction.
Why it matters: Getting a credit facility is important. It helps fund future operations and growth.
Supportive ifThere is news about a secured credit facility. It will help with capital needs.
Worry ifThere are no updates or delays in getting a credit facility.
Why it matters: Higher placements signal strong demand and support recurring revenue growth. This is key for LENSAR's strategy.
Supportive ifIn Q3, ALLY systems placed more than 10 units. This shows strong market demand.
Worry ifIn Q3, placements are below 10 units. This shows weaker demand for ALLY systems.
Why it matters: Sustained high growth in recurring revenue shows the health of LENSAR's business model.
Supportive ifRecurring revenue growth in Q3 remains above 20% year over year.
Worry ifRecurring revenue growth in Q3 drops below 20% year over year.
Why it matters: Positive net income means the company makes more money. This is important for investor trust.
Supportive ifNet income in Q3 is positive. This shows the company is still making money.
Worry ifNet income in Q3 is negative. This shows possible problems in operations.
Why it matters: A growing backlog means strong future demand. This helps support revenue growth.
Supportive ifThe backlog of ALLY systems is over 15 units. This shows strong future demand.
Worry ifThe backlog of ALLY systems is 13 units or less. This signals weaker demand.